bioAffinity Technologies, Inc. (BIAF) Net margin 2022–2025
bioAffinity Technologies, Inc. (BIAF) net profit margin by fiscal year — reported net income divided by reported revenue.
-242.0%FY2025 · since FY2022: -169771.2% → -242.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -242.0% | -145.4 pp |
| FY2024 | -96.6% | +216.8 pp |
| FY2023 | -313.4% | +169457.8 pp |
| FY2022 | -169771.2% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BIAF financial trends
BIAF RevenueBIAF Net incomeBIAF Gross profitBIAF Gross marginBIAF Operating incomeBIAF Operating marginBIAF Operating cash flowBIAF Free cash flowBIAF Capital expendituresBIAF Return on equityBIAF Stock buybacksBIAF Dividends paidBIAF Total assetsBIAF Total liabilitiesBIAF Shareholders’ equityBIAF overview →